Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 5 of 5 items.
Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
AlertHealth professional risk communication | 2021-07-30
CHAMPIX (varenicline) — Potential Risk Posed by Long-Term Exposure to Nitrosamine Impurity, N-nitrosovarenicline, Exceeding Acceptable Intake Limit
AlertHealth professional risk communication | 2021-06-30
GILENYA (fingolimod) - Risk of Liver Injury
AlertHealth professional risk communication | 2021-01-18
Important Safety Information on SUBOXONE (buprenorphine and naloxone) and the Risk of Overdose or Underdose when Switching Between Dosage Forms or Routes of Administration
AlertHealth professional risk communication | 2021-01-07
Importation of German-labelled Hydromorphon Ethypharm Kalceks (Hydromorphone Hydrochloride Solution for Injection) due to Potential Shortage of Canadian-labelled HYDROmorphone
AlertHealth professional risk communication | 2021-01-06